Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Objectives: Designing studies with an internal pilot phase may optimise the use of pilot work to inform more efficient randomised controlled trials (RCTs). Careful selection of preagreed decision or ‘progression’ criteria at the juncture between the internal pilot and main trial phases provides a valuable opportunity to evaluate the likely success of the main trial and optimise its design or, if necessary, to make the decision not to proceed with the main trial. Guidance on the appropriate selection and application of progression criteria is, however, lacking. This paper outlines the key issues to consider in the optimal development and review of operational progression criteria for RCTs with an internal pilot phase. Design: A structured literature review and exploration of stakeholders' opinions at a Medical Research Council (MRC) Hubs for Trials Methodology Research workshop. Key stakeholders included triallists, methodologists, statisticians and funders. Results: There is considerable variation in the use of progression criteria for RCTs with an internal pilot phase, although 3 common issues predominate: trial recruitment, protocol adherence and outcome data. Detailed and systematic reporting around the decision-making process for stopping, amending or proceeding to a main trial is uncommon, which may hamper understanding in the research community about the appropriate and optimal use of RCTs with an internal pilot phase. 10 top tips for the development, use and reporting of progression criteria for internal pilot studies are presented. Conclusions: Systematic and transparent reporting of the design, results and evaluation of internal pilot trials in the literature should be encouraged in order to facilitate understanding in the research community and to inform future trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In effectiveness trials, power calculations and sample size decisions are primarily based on the detection of a clinically meaningful difference in measures of the effects of the intervention on the patient or public health outcomes such as behaviour, disease, symptomatology or functional outcomes [24].”
From Guidance for conducting feasibility and pilot studies for implementation trials (2020) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Feasibility and acceptability were operationalized a priori according to the following progression criteria thresholds: stop (benchmark: < 70%), adapt (> 70%- < 90%), and go (> 90%).”
From Yoga-Based Group Intervention for Inpatients with Schizophrenia Spectrum Disorders—Feasibility, Acceptability, and Preliminary Outcomes of a Rater-Blinded Randomized Controlled Trial. (2026) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These results give solid ground for the likely success of a following fully powered RCT investigating the intervention’s efficacy32 and align with previous findings on MBIs for SSD.22”
From Yoga-Based Group Intervention for Inpatients with Schizophrenia Spectrum Disorders—Feasibility, Acceptability, and Preliminary Outcomes of a Rater-Blinded Randomized Controlled Trial. (2026) · cites this paper as [32]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Thus, it aligns with the main aims and objectives of pilot and feasibility studies and with the progression stop-amend-go recommendations of Eldridge et al. [2] and Avery et al. [18].”
From Determining sample size for progression criteria for pragmatic pilot RCTs: the hypothesis test strikes back! (2021) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Avery et al. [18] published recommendations for internal pilots emphasising a traffic light (stop-amend-go/red-amber-green) approach to progression with focus on process assessment (recruitment, protocol adherence, follow-up) and transparent reporting around the choice of trial design and the decision-making processes for stopping, amending or proceeding to a main trial.”
From Determining sample size for progression criteria for pragmatic pilot RCTs: the hypothesis test strikes back! (2021) · cites this paper as [18]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Developing and evaluating complex interventions: the new Medical Research Council guidance
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M. (2008) · BMJ · doi:10.1136/bmj.a1655 · Cited by 10,995
CONSORT 2010 statement: extension to randomised pilot and feasibility trials.
Eldridge, S. M., Chan, C. L., Campbell, M. J., Bond, C. M., Hopewell, S., Thabane, L., & Lancaster, G. A. (2016) · BMJ · doi:10.1136/bmj.i5239 · Cited by 3,404
A tutorial on pilot studies: the what, why and how
Thabane, L., Ma, J., Chu, R., Cheng, J., Ismaila, A., Rios, L. P., Robson, R., Thabane, M., Giangregorio, L., & Goldsmith, C. H. (2010) · BMC Medical Research Methodology · doi:10.1186/1471-2288-10-1 · Cited by 3,384
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. J. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,930
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
on behalf of the PAFS consensus group, Eldridge, S. M., Chan, C. L., Campbell, M. J., Bond, C. M., Hopewell, S., Thabane, L., & Lancaster, G. A. (2016) · Pilot and Feasibility Studies · doi:10.1186/s40814-016-0105-8 · Cited by 2,843
Design and analysis of pilot studies: recommendations for good practice
Lancaster, G. A., Dodd, S., & Williamson, P. R. (2004) · Journal of Evaluation in Clinical Practice · doi:10.1111/j..2002.384.doc.x · Cited by 2,572 · cited 1×
“In addition, the assumption that pilot studies are less rigorous than main studies and are not designed to test the main trial hypothesis means that their findings are underdisseminated, thereby preventing triallists from accessing information that may be valuable to the success of future main trials.(3) 10 The system…”
BackgroundSelf-citationFundamentals of Clinical Trials
Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015) · doi:10.1007/978-3-319-18539-2 · Cited by 2,237
No surgical innovation without evaluation: the IDEAL recommendations
McCulloch, P., Altman, D. G., Campbell, W. B., Flum, D. R., Glasziou, P., Marshall, J. C., & Nicholl, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61116-8 · Cited by 1,820
Developing and evaluating complex interventions: the new Medical Research Council guidance
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M. (2013) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2012.09.010 · Cited by 1,658
Eldridge, S. M., Lancaster, G. A., Campbell, M. J., Thabane, L., Hopewell, S., Coleman, C. L., & Bond, C. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150205 · Cited by 1,581
Cited by
Items 301–400 of 577
Deere, R., Pallmann, P., Shepherd, V., Brookes‐Howell, L., Carson‐Stevens, A., Davies, F., Dunphy, E., Gupta, P., Hickson, M., Hill, V., et al. (2024) · Trials · doi:10.1186/s13063-024-08380-7 · Cited by 1
“An internal pilot will be carried out from the start of recruitment and assessed after 6 months using a traffic light system [53, 54].”
MethodTemkin, A. B., Ayaz, A., Blicker, E., Liu, M. X., Oh, A., Siegel, I. E., Seewald, M. J., Hermann, A. D., Givrad, S., Baez, L. M., et al. (2025) · JMIR Research Protocols · doi:10.2196/59461 · Cited by 1
Conneely, M., O’Sullivan, K., Ryan, C. G., Clifford, A. M., Coote, S. B., Eshghimanesh, Z., Sullivan, V. O., Robinson, K., Shiely, F., Glynn, L. G., et al. (2024) · HRB Open Research · doi:10.12688/hrbopenres.13981.1 · Cited by 1
Sheehan, K. J., Guerra, S., Ayis, S. A., Goubar, A., Foster, N. E., Martin, F. C., Godfrey, E. L., Cameron, I. D., Gregson, C. L., Walsh, N. E., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306870 · Cited by 1
Amorim, A. B., Rebbeck, T. J., Dam, N. T. V., Johnstone, C. S. H., Ashton-James, C. E., Costa, N., Barnet-Hepples, T., Jennings, M., Refshauge, K. M., & Pappas, E. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01612-w · Cited by 1
“Our progression criteria for the trial will follow the traffic light system proposed by Avery and colleagues [39], where achieving green (go)—80% retention rate—indicates that the criteria have been met, and the trial should proceed, achieving amber (amend)—60% retention rate—indicates that some…”
Krawcyk, R. S., Amdi, K. V., Kruuse, C. R., & Thomsen, T. (2025) · Journal of Rehabilitation Medicine · doi:10.2340/jrm.v57.42881 · Cited by 1
“The results from this qualitative study together with the results of the initial feasibility study will inform the design of a subsequent larger randomized controlled trial (8).”
Wilson, D. T., Hall, A., Brown, J. M., & Walwyn, R. E. A. (2025) · Statistical Methods in Medical Research · doi:10.1177/09622802251322987 · Cited by 1
Morrell, A. T., Shelofsky, S., Hoffman, H., McCallister, C., Huff, T. W., Schabel, K., O’Glasser, A. Y., & Kagan, R. P. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-091446 · Cited by 2
Kelly, N. R., Doty, K. J., Schrag, B. H. C., Bryant, S., Plezia, S., Parr, N. J., & Budd, E. L. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01630-8 · Cited by 1
“Well-defined progression criteria are used to determine whether to proceed to a definitive trial and to inform important changes to the study protocol (e.g., if the amount of missing data was below acceptable criteria, reconsidering data collection strategies; see [84] for specific suggestions).”
Halliday, B., Chatfield, S., Cameron, L., Hosking, J., Chynoweth, J., Stockley, L., Bailey, M. P., Shawe, J., Hawton, A., Hayward, C. J., et al. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01638-0 · Cited by 5
“Progression criteria were set, using a red, amber, and green (RAG) rating system to decide whether, and how, to proceed with a future definitive trial [37].”
Juckett, L., Joshi, S., Hyer, J. M., Hariharan, G., Thomas, K. S., Sathya, T. S., Howard, M. L., Bunck, L. E., Rowe, M. L., Devier, A., et al. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06008-2 · Cited by 1
Bindicsova, I., Hides, L. M., Brain, K., Hodson, F. J., Jackson, P., Jensen, M. P., Ehde, D. M., & Day, M. A. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105429 · Cited by 3
STEPHENS, N., Evans, S., Russell, C., & Brooker, D. (2025) · Behavioral Sciences · doi:10.3390/bs15050670 · Cited by 1
“We argue that that is not true and that fidelity and, by extension, feasibility should be framed pragmatically as dynamic processes exhibiting varying levels of adherence and viability (Avery et al., 2017).”
Pérez, B. D. D., Kendrick, D., das Nair, R., Evangelou, N., Newsome, I., & Radford, K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325570 · Cited by 1
Souto, L. R., Pazzinatto, M. F., Silva, D. D. O., Ezzat, A. M., & Barton, C. J. (2025) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2025.152787 · Cited by 1
Kato, D., Hirano, S., Imoto, D., Ii, T., Matsuura, D., Ishihara, T., & Otaka, Y. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01694-6 · Cited by 1
“Even if a participant fails to meet any of the four established criteria, the study will proceed with protocol modifications if the underlying issues can be addressed [29].”
McGlashan, J. A., Aaen, M., White, A., Saccente‐Kennedy, B., Tempesta, M., & Sadolin, C. (2025) · Journal of Voice · doi:10.1016/j.jvoice.2025.07.044 · Cited by 3
Arden-Close, E. J., Thomas, S., Bush‐Evans, R., Hamson-Ford, A., Bolat, E., Hodge, S., Phalp, K. T., Wang, R., & McAlaney, J. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-104784 · Cited by 1
“The study manager and research team members were asked to inform the chief investigator of any concerning communications or potential adverse events (AEs) received or reported via WIRE, email or during interviews.”
Carson, T. L., Llanos, A. A. M., Fleming, K., Pittman, S., Pena, A., Henderson, J., Doerr, V., Cooper, A. J., Mallory, M. A., Sutton, S. K., et al. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2025.108113 · Cited by 1
Gaewkhiew, P., Chatyanan, S., Supavaree, S., Chaiueai, A., Vimolratchataporn, A., & Sridonpai, P. (2025) · BMC Public Health · doi:10.1186/s12889-025-24655-3 · Cited by 1
“If the trial fails to meet key criteria, indicating significant challenges that may not be addressable in a full RCT : Do not Proceed [13].”
Hossain, S., Beard, E., & Shahab, L. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01710-9 · Cited by 1
“To inform the decision on whether to proceed to a future definitive trial, pre-specified progression criteria will be applied using a traffic light system [52].”
Adams, E. L., Savidge, M., Reesor-Oyer, L. M., Draper, C. L., Steeves, E. A., Bean, M. K., Figueroa, R., Stephenson, K., Weaver, R. G., Armstrong, B., et al. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01732-3 · Cited by 1
“Following recommendations [47], progression criteria were established as a guide for determining the appropriateness of advancing to a larger efficacy trial.”
Beneciuk, J. M., Bialosky, J. E., Harrison, T., Buzzanca-Fried, K. E., Rodgers, L. J., & Verstandig, D. (2025) · Physical Therapy · doi:10.1093/ptj/pzaf152 · Cited by 2
Vilardaga, R., McClernon, F. J., Akingbule, O., Mannelli, P., Thomas, S. M., Davis, J. M., Gray, M. F., Arnold, C., Reyes, I. C. K., Ashare, R. L., et al. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.113015 · Cited by 1
Kramer, C. B., Rao, M., Coultas, D., Young, J. P., Sayre, G. G., Locke, E. R., Fennell, T., Weiner, B. J., Nelson, K. M., Jones‐Smith, J. C., et al. (2026) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01711-8 · Cited by 1
“Several recent studies document these best practices to help more objectively and systematically evaluate criteria for recommending moving forward from pilot to full trial [58, 59].”
Metwally, M., McKendrick, K., Ridsdale, K., Pye, C., Walters, S., Amer, S., Barr, A., Chatters, R., Cheong, Y. C., Choudhary, M. K., et al. (2026) · Health Technology Assessment · doi:10.3310/gjmm1915 · Cited by 1
Busse, J. W., Flood, B., Madden, K., Ashoorion, V., Olaonipekun, E., Atrey, A., Khanna, V., Adili, A. F., the Cannabis-TKA Investigators, Weerdenburg, A., et al. (2026) · Pilot and Feasibility Studies · doi:10.1186/s40814-026-01822-w · Cited by 1
Tang, Y., Gierc, M. S. H., Liu, S., Lam, R. W. M., Puterman, E. M., & Faulkner, G. (2026) · JMIR Formative Research · doi:10.2196/79033 · Cited by 1
“The traffic light system [37] was used to determine progression to a randomized controlled trial (RCT) for efficacy testing.”
Arundel, C., Mandefield, L., Fairhurst, C. M., Baird, K., Saramago, P., Gkekas, A., Macefield, R. C., Blazeby, J. M., Corbacho, B., Dixon, S., et al. (2025) · Health Technology Assessment · doi:10.3310/gjic1716 · Cited by 1
Self-citationFordham, B., Quarmby, L. M., Costa, M. L., Painton, R., Draper, K., Knight, R., Achten, J., Appelbe, D., Merrill, J., Franssen, M., et al. (2026) · The Bone & Joint Journal · doi:10.1302/0301-620x.108b6.bjj-2025-1309.r1 · Cited by 1
Graham, H., Madigan, C. D., & Daley, A. (2023) · Journal of Behavioral Medicine · doi:10.1007/s10865-023-00455-1 · Cited by 2
“The “traffic light” red (do not proceed)/amber (proceed with modifications)/green (proceed) system is a method of representing the progression for a trial in a simple and transparent way and has been used widely in other feasibility studies (Avery et al., 2017).”
MethodKiernan, A., Boland, F., Naughton, P. A., Moneley, D. S., Doyle, F., & Harkin, D. W. (2024) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2024.02.030 · Cited by 3
A Pilot Acceptance and Commitment Intervention for Parents of Children With RASopathies
Little, P., Ghriwati, N. A., Siegel, A., Toledo‐Tamula, M. A., Curlee, M. S., Baker, M., Rogge, R. D., Yohe, M. E., Gross, A. M., & Martin, S. C. (2025) · Clinical Practice in Pediatric Psychology · doi:10.1037/cpp0000551 · Cited by 2
Arundel, C., Zahra, S., Chetter, I. C., on behalf of the SWHSI-2 Trial Investigators, Baird, K., Martin, B. C., Hewitt, C., Fairhurst, C., Gkekas, A., Mott, A., et al. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01658-w · Cited by 1
“As a result, the number of RCTs including internal pilots is increasing; however, their findings are rarely disseminated [10, 16], despite previous research encouraging the systematic reporting of the design, results and evaluation of internal pilot trials [14].”
InfluentialSelf-citationWright, K. A., Warren, F. C., Bucci, S., Dunn, B. D., Jones, S. H., O’Mahen, H., Taylor, R. S., & Medina‐Lara, A. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01678-6 · Cited by 1
“The criteria for progression to definitive trial are given in Table 1, presented in accordance with the framework proposed by Avery and colleagues [27].”
Walsh, C. B., Cahalan, R., Julian, N., Hinman, R. S., & Sullivan, K. O. (2025) · Physiotherapy Practice and Research · doi:10.1177/22130683251341698 · Cited by 1
Garma, L. D., Pernas, S., Baz, D. V., Campelo, R. G., Terrasa, J., Nasarre, B., Vera, R., Bermejo, B., González-Santiago, S., Fullana, B., et al. (2026) · JCO Precision Oncology · doi:10.1200/po-25-01185 · Cited by 2
Kiernan, A., Boland, F., Moneley, D. S., Doyle, F., & Harkin, D. W. (2023) · Pilot and Feasibility Studies · doi:10.1186/s40814-023-01336-9 · Cited by 1
“Continuation criteria Continuation criteria (Table 1) will be considered to determine whether further evaluation of this intervention is warranted (to test the effectiveness of the intervention) [41, 42].”
BackgroundKaye, S. S., Lewandowski, A., Dunne, M., Bowman, J., & Archer, V. (2022) · Pilot and Feasibility Studies · doi:10.1186/s40814-022-01068-2 · Cited by 1
Rowe, K., Pozuelo, J. R., Nickless, A., Nkosi, A. D., dos Santos, A., Kahn, K., Tollman, S. M., Wagner, R. G., Scerif, G., & Stein, A. L. (2023) · AIDS Care · doi:10.1080/09540121.2023.2195607 · Cited by 2
“We de fi ned our progression criteria for progression from a feasibility trial through to a full-scale RCT (Table 1) using a red/amber/green tra ffi c light system (Avery et al., 2017).”
MethodPilot and feasibility studies – more than just measuring metrics
Shah, A., Gustafson, O. D., & Vollam, S. (2020) · Anaesthesia · doi:10.1111/anae.15019 · Cited by 1
“It is therefore disappointing that only 56% of randomised controlled trials funded by National Institute for Health Research Health Technology Assessment programme trials reach their final recruitment target [2].”
BackgroundHynes, S. M., Dwyer, C. P., Alvarez‐Iglesias, A., Rogers, F., Joyce, R. A., Oglesby, M. H., Moses, A., Bane, E., Counihan, T. J., Charamba, B., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4151380/v1 · Cited by 1
Pilot and feasibility studies in ophthalmology: fundamental keys to success
Nanji, K., Phillips, M., Thabane, L., Tham, Y. C., Wong, T. Y., STEEL, D. H., Munk, M. R., Wykoff, C. C., Chaudhary, V., On behalf of the Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group, et al. (2024) · Eye · doi:10.1038/s41433-024-03413-6 · Cited by 1
Timms, L., Rodd, H., Brocklehurst, P., Deery, C., & Marshman, Z. (2026) · BMC Oral Health · doi:10.1186/s12903-026-08442-z
“The sample size was based on Sim and Lewis’ (2012) suggestion of requiring at least 50 participants to determine the variability of the primary outcome measure and the ability to estimate parameters of uncertainty within 95% confidence intervals of 10% [20, 21].”
Pilot Studies in Clinical Research
Whitehead, A. L., & Julious, S. A. (2020) · Wiley eBooks · doi:10.1002/9781118445112.stat08205 · Cited by 2
Robinson, H. (2020) · Lincoln Repository (University of Lincoln) · doi:10.24385/lincoln.24326446
Home monitoring of kidney function in cancer patients: assessing acceptability and clinical benefit
Ogden, L. (2019) · http://isrctn.com/ · doi:10.1186/isrctn11076307
Yuasa, A., Uehara, S., Ushizawa, K., Toyama, T., Gomez-Tames, J. D., Hirata, A., & Otaka, Y. (2022) · Pilot and Feasibility Studies · doi:10.1186/s40814-022-01223-9 · Cited by 2
Developing, Implementing and Evaluating Complex Services/Interventions, and Generating the Evidence
Cadogan, C. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-50247-8_54-1
(2023) · University of Glasgow · doi:10.3310/nihropenres.14394.r29120
(2023) · Monash University · doi:10.3310/nihropenres.14394.r29073
Cooke, S., Pennington, K., Bridle, C., & Curtis, F. (2023) · Diabetology · doi:10.3390/diabetology4020016
(2023) · University of Glasgow · doi:10.3310/nihropenres.14565.r29198
(2023) · Monash University · doi:10.3310/nihropenres.14565.r29197
Urquhart, D. S., Cunningham, S., Taylor, E., et al. (2023) · NIHR Open Research · doi:10.3310/nihropenres.14474.r29279
Urquhart, D. S., Cunningham, S., Taylor, E., et al. (2023) · NIHR Open Research · doi:10.3310/nihropenres.14474.r29271
Montejo, R., Hermansson, J., Nilsson, A., Arkel, E., Keller, L., & Gutke, A. (2023) · Research Square · doi:10.21203/rs.3.rs-3288302/v1
A pragmatic approach to mobile attention bias modification in a clinical setting
Zhang, M. W. (2023) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/170488
Developing, Implementing and Evaluating Complex Services/Interventions, and Generating the Evidence
Cadogan, C. A. (2023) · Springer eBooks · doi:10.1007/978-3-030-64477-2_54
Sheehan, K. J., Bastas, D., Guerra, S., Creanor, S., Hulme, C. T., Lamb, S. E., Martin, F. C., Sackley, C. M., Smith, T. O., Bell, P., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306871 · Cited by 1
Wadman, R., Taylor, O., Hudson, K., Lewer, D., Hewitt, C. E., Pickavance, J., Pryce, J., Wright, J., & Gilbody, S. M. (2024) · NIHR Open Research · doi:10.3310/nihropenres.13678.1
A Bayesian adaptive feasibility design for rare diseases
Churipuy, M. M., Golchi, S., Hudson, M., & Hoa, S. A.-T. (2024) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2024.101392 · Cited by 1
“Following recommendations proposed in the literature, the number and size of sites chosen to be included in the pilot trial should reflect the range of clinical sites that will be used during the phase III trial [4].”
InfluentialThe Effect of Legitimacy Training on Audience Legitimacy
Langley, B., & Ariel, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-74367-2_6
Pani, J., Fiorini, L., Rovini, E., & Cavallo, F. (2024) · Lecture notes in bioengineering · doi:10.1007/978-3-031-77318-1_36
Emotion Focused and Schema Therapy for Anorexia Nervosa: The SPEAKS Approach
Oldershaw, A., & Startup, H. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-46096-8_105
Energetic activity for depression in young people aged 13–17 years: the READY feasibility RCT
Smith, M., James, R., Howlett, N., Mengoni, S. E., Jones, J., Sims, E. J., Turner, D., Grant, K., Clark, A., Murdoch, J., et al. (2024) · Health Technology Assessment · doi:10.3310/kwnh4507
O’Leary, H., Toomey, C., Ryan, L. G., Robinson, K., Glynn, L. G., French, H., & McCreesh, K. M. (2025) · HRB Open Research · doi:10.12688/hrbopenres.14049.1
Knowledge of traffic signs among students of the industrial engineering department at K university
Rizalmi, S. R., Sulaiman, M., Sudarni, A. A. C., Setiowati, N. O., & Febriyanti, N. N. M. (2025) · AIP conference proceedings · doi:10.1063/5.0227774
Hitchman, L. H., Iglesias, C., Russell, D., Smith, G., Twiddy, M., & Chetter, I. C. (2025) · International Wound Journal · doi:10.1111/iwj.70176
“The Stop/Go criteria [50] are: – Green (continue): > 60% recruitment, adherence to treat-ment arm and follow-up attendance per month.”
SKILLTRAIN ABS v1Preprint
Zlámal, J., Barbu, C., Baglo, M. C., Hagen, H.-M. D., & Heyn, L. (2025) · doi:10.17504/protocols.io.dm6gpd8mdgzp/v1
Futility Interim Analyses - A Plea for Simplicity
Thanei, G., Klingelschmitt, G., Berge, C., & Burger, H. U. (2025) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-025-00779-x
Muirhead, R., Kynoch, K., Hawley, G., Ballard, E. L., Birch, P., & Lewis, P. (2025) · Journal of Advanced Nursing · doi:10.1111/jan.16992
“The ‘traffic light’ red (do not proceed), amber (proceed with modifications) and green (proceed) system is a method of representing the progression for a trial in a simple and transparent way and has been used widely in other feasibility studies (Avery et al. 2017; Herbert et al. 2019).”
Feasibility of a Finger Food Menu for Older Adults Post Stroke in Hospital
Heelan, M., Prieto, J. A., Barnes, C. J., & Green, S. M. (2025) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.70061
Hirschey, R., Xu, J., Woodard, N., Duggins, P., Lea, D. F., Milner, J. L., Coleman, K., Bryant, A. L., Sanoff, H. K., Triglianos, T., et al. (2025) · JMIR Research Protocols · doi:10.2196/65804
“This decision is based on recommendations for pilot studies, which suggest selecting a threshold that allows identifying areas where adaptations and improvements can be made in a subsequent efficacy trial [26].”
Naz, S., Ilyas, M., & Iqbal, R. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01662-0 · Cited by 1
“…at least 50 is required to determine the variability of the feasibility outcomes, such as recruitment and retention rates of students and the rate for completing the structured diaries, and changes in the shared risk factors of NCD at post-intervention assessment compared to the baseline [21, 22].”
Babu, A. S., & Taylor, R. S. (2025) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvaf145
Botchway-Commey, E. N., Burton, C., Pace, C. C., Ehrenreich, J. T., Kennedy, S. M., Williams, J. S., Poulakis, Z., DPsychClin, A. M., Anderson, V. A., & Crowe, L. M. (2025) · BMC Psychology · doi:10.1186/s40359-025-03052-w
Paiva, E. M. D. C., Moura, C. D. C., Fonseca, N. D. S. M., & Garcia, A. C. M. (2025) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2025.100559
Hansen, L. K., Krogh, L. Q., Lantto, A., Uldbjerg, N., Jensen, P. T., Shennan, A. H., Hald, K., Heikinheimo, O., Jacobsson, B., Hjartardóttir, H., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-107093
“19 Participants will be randomised in a 1:1 ratio in permuted blocks of 4, 6 and 8 to either lapTAC or TVC with stratification according to country.”
White, A., Booth, V., Carding, P. N., Stan, J. H. V., McGlashan, J. A., Saccente‐Kennedy, B., Awad, R., Logan, P., & Britton, D. (2025) · Journal of Voice · doi:10.1016/j.jvoice.2025.08.024
Taggart, L., McDermott, G., Dunkley, A. J., Truesdale, M., COATES, V. E., Khunti, K., Clarke, M. J., Pollard, D. J., Brennan, A., Hadjiconstantinou, M., et al. (2025) · NIHR Open Research · doi:10.3310/nihropenres.13964.1 · Cited by 1
“We will use Avery et al., 29 traffic light system to guide our progression criteria as recommended in recent best practice.”
Yang, Y., Green, K. L., Zhang, N., McGarrigle, L., & Todd, C. J. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01693-7 · Cited by 1
Day, M. A., Ciol, M. A., Ehde, D. M., Mendoza, M. E., Borckardt, J. J., Newman, A. K., Chan, J. F., Friedly, J. L., Reed, D. E., Drever, S. A., et al. (2025) · Pain Practice · doi:10.1111/papr.70107
Hillier, K. L., Eley, V. A., Humphrey, T., Ballard, E. L., & Lee, N. (2025) · Women and Birth · doi:10.1016/j.wombi.2025.102134
Schoffl, J., Arora, M., Pozzato, I., McBain, C., Rodrigues, D., Vafa, E., Middleton, J. W., Davis, G. M., Bourke, J., Krassioukov, A. V., et al. (2025) · BMC Neurology · doi:10.1186/s12883-025-04423-x
Yinusa, G., Surr, C., Thomas, S., Fenge, L., Howdon, D., Major, J., Heward, M., Taylor, G. T., Knight, H. P., Townson, J., et al. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01722-5
“…as part of the screening process, we will identify the expected number of family carer dyads potentially eligible from each participating organisation’s database and the conversion rate of those who consented to participate [51], i.e. if we can recruit more than 10 dyads from 100 eligible dyads.”
Grønfeldt, B. M., Skou, S. T., Kirk, J. W., Troelsen, A., Bandholm, T., Tjørnhøj‐Thomsen, T., Thorborg, K., Ehlers, L. H., Rathleff, M. S., Mikkelsen, L. R., et al. (2025) · Osteoarthritis and Cartilage Open · doi:10.1016/j.ocarto.2025.100708
“To facilitate clear interpretations of the trial's feasibility, relevant criteria were determined as suggested by both Thabane and colleagues and Avery and colleagues [23,24].”
Nielsen, S. S., Christensen, J. R., Tang, L. H., Simonÿ, C., Skejø, S. D., & Skou, S. T. (2025) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2025.09.028
Hansen, M. C., Uhrenfeldt, L., Ingstad, K., & Pedersen, P. U. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01745-y · Cited by 3
“Following Avery et al. [43] preliminary studies’ success in trial recruitment, protocol adherence, and completeness of outcome data may provide a guideline for assessing whether the full-scale study should be continued unchanged, continued with changes, or stopped before a full-scale trial.”
Lourenço, B. M., de Miranda, J. P., Fukusawa, L., de Jesus‐Moraleida, F. R., Hespanhol, L., Cabral, C. M. N., Saragiotto, B. T., Lima, P. O. D. P., & Oliveira, V. C. (2025) · Brazilian Journal of Health Review · doi:10.34119/bjhrv8n6-373
Kirwan, C., Hynes, L., Hart, N. D., Mulligan, S., Leathem, C. S., McQuillan, L., Maxwell, M., Carr, E., Roche, K., Walkin, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21273885
Pellet, J., Weiss, M., Zúñiga, F., & Mabire, C. (2021) · Figshare · doi:10.6084/m9.figshare.14234533
Additional file 2 of Guidance for conducting feasibility and pilot studies for implementation trials
Pearson, N., Naylor, P.-J., Ashe, M. C., Fernandez, M., Yoong, S. L., & Wolfenden, L. (2020) · Figshare · doi:10.6084/m9.figshare.13173941
Dimairo, M., Pallmann, P., Wason, J. M. S., Todd, S., Jaki, T., Julious, S. A., Mander, A., Weir, C. J., Koenig, F., Walton, M. K., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12494876
Røpke, A., Morville, A.-L., Møller, T. E., Delkus, E. C. G., & Juhl, C. B. (2022) · Figshare · doi:10.6084/m9.figshare.19669888
Radisic, G., Duncanson, E., Leu, R. K. L., Collins, K., Burke, A. L., Turner, J. K., Chur‐Hansen, A., Donnelly, F., Hill, K. E., McDonald, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19126293
Li, G., Wu, D., Chen, X., Zeng, J., Li, Z., & Thabane, L. (2020) · Figshare · doi:10.6084/m9.figshare.12177828
Dimairo, M., Pallmann, P., Wason, J. M. S., Todd, S., Jaki, T., Julious, S. A., Mander, A., Weir, C. J., Koenig, F., Walton, M. K., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12494858
Shaw, L., McCue, P., Brown, P. E., Buckley, C., Del Din, S., Francis, R. P., Hunter, H., Lambert, A., Lord, S., Price, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21547175
Metadata
- Authors
- Avery, K. N. L., Williamson, P. R., Gamble, C., O'Connell Francischetto, E., Metcalfe, C., Davidson, P., Williams, H., & Blazeby, J. M.
- Affiliations
- University of Bristol (GB)
- University of Liverpool (GB)
- Medical Research Council ConDuCT-II Hub for Trials Methodology Research, School of Social and Community Medicine, University of Bristol, Bristol, UK
- National Institute for Health and Care Research (GB)
- Nottingham University Hospitals NHS Trust (GB)
- University Hospitals Bristol NHS Foundation Trust (GB)
- Corresponding author
- Avery, Kerry N L
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2017-02
- Volume
- 7
- Issue
- 2
- Pages
- e013537
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC5318608
- OpenAlex
- W2588182016
- Semantic Scholar
- c03117980919b954181d0ea10371c6c6561bde41
- Cited by
- 575
- References
- 48
- Citations by year
- 2026: 83 · 2025: 100 · 2024: 90 · 2023: 83 · 2022: 69 · 2021: 67 · 2020: 49 · 2019: 20 · 2018: 13 · 2017: 1
- FWCI
- 15.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMJ Open (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- ResearchOnline (Glasgow Caledonian University) (acceptedVersion, other-oa)
- Keele Research Repository (Keele University) (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Stirling Online Research Repository (University of Stirling) (submittedVersion, cc-by)
- UCL Discovery (University College London) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Ulster University Research Portal (Ulster University) (submittedVersion, other-oa)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion, other-oa)
- Explore Bristol Research (submittedVersion, cc-by)
- Funders
- National Institute for Health and Care Research (DRF-2011-04-016, NF-SI-0611-10020, DRF-2012-05-182)
- Medical Research Council (MR/K025635/1, MR/L004933/1, MR/K025643/1, MR/L004933/2)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Keywords
- internal pilot study, progression criteria, randomized controlled trials, trial design, trial recruitment, protocol adherence, outcome data, trial reporting, stakeholder perspectives, trial efficiency
- MeSH terms
- Attitude, Clinical Protocols, Decision Making, Humans, Pilot Projects, Research Design, Research Personnel, Randomized Controlled Trials as Topic, Outcome Assessment, Health Care, Patient Selection, Guideline Adherence, Clinical Trials Data Monitoring Committees, Research Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.